|
Press Releases |
|
![](/images/company/Moderna220.jpg) |
|
Tuesday, March 26, 2024 |
|
Moderna Achieves Positive Interim Results from Phase 3 Trial of Next-Generation COVID-19 Vaccine |
Moderna, Inc. (NASDAQ:MRNA) today announced that mRNA-1283, the Company's next-generation COVID-19 vaccine, has successfully met the primary endpoints of its Phase 3 clinical trial, demonstrating a higher immune response against SARS-CoV-2 when compared to mRNA-1273.222, Moderna's licensed COVID-19 vaccine. more info >> |
|
Monday, December 11, 2023 |
|
Moderna公司回顧了在第二次環境、社會和治理(ESG)投資者活動中取得的進展和雄心 |
more info >> |
|
Moderna Reviews its Environmental, Social and Governance (ESG) Progress and Ambitions at Second ESG Investor Event |
more info >> |
|
Wednesday, July 5, 2023 |
|
Moderna Announces Global Regulatory Submissions for Its Respiratory Syncytial Virus (RSV) Vaccine, MRNA-1345 |
Moderna, Inc. (Nasdaq:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today provided an update on regulatory submissions for mRNA-1345, a vaccine for the prevention of RSV-associated lower respiratory tract disease (RSV-LRTD) and acute respiratory disease (ARD) in adults aged 60 years or older. more info >> |
|
Wednesday, May 3, 2023 |
|
Moderna Announces Establishment of an Enterprise Solutions Hub and Commercial Operations in The Philippines |
Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced plans to establish an Enterprise Solutions Hub in the Philippines. The Moderna Enterprise Solutions Hub will provide business services across the Asia Pacific region, where Moderna currently has operations in six markets. Moderna also plans to establish commercial operations in the Philippines. more info >> |
|
Moderna Announces Establishment of an Enterprise Solutions Hub and Commercial Operations in The Philippines |
Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced plans to establish an Enterprise Solutions Hub in the Philippines. The Moderna Enterprise Solutions Hub will provide business services across the Asia Pacific region, where Moderna currently has operations in six markets. Moderna also plans to establish commercial operations in the Philippines. more info >> |
|
Tuesday, September 13, 2022 |
|
Indonesia's Bio Farma ready to produce IndoVac Covid-19 vaccines |
PT Bio Farma, the holding company for state-owned pharmaceutical companies in Indonesia, announced a new milestone in manufacturing IndoVac, a Covid-19 vaccine brand it has developed since November 2021. more info >> |
|
Friday, September 9, 2022 |
|
Indonesian pharmaceutical Bio Farma ready to produce IndoVac Covid-19 vaccines |
PT Bio Farma, the holding company for state-owned pharmaceutical companies in Indonesia, announced a new milestone in the manufacturing process of IndoVac, a Covid-19 vaccine brand it has developed since November 2021. more info >> |
|
Tuesday, July 19, 2022 |
|
Therapeutic Goods Administration Grants Provisional Approval for Moderna's COVID-19 Vaccine in Children Aged Six Months to Five Years |
Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that the Therapeutic Goods Administration (TGA) in Australia has granted provisional registration for the use of Moderna's mRNA COVID-19 vaccine, Spikevax, in a two-dose series of 25 ug per dose for active immunization to prevent COVID-19 caused by SARS-CoV-2 in children aged 6 months to 5 years. more info >> |
|
Thursday, February 17, 2022 |
|
Therapeutic Goods Administration of Australia Authorizes Moderna's Covid-19 Vaccine in Children (6-11 Years) |
Moderna, Inc., (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that the Therapeutic Goods Administration (TGA) in Australia has granted provisional registration for the use of Moderna's mRNA COVID-19 vaccine, Spikevax, in a 50 ug dose, two-dose series, for active immunization to prevent COVID-19 caused by SARS-CoV-2 in children aged 6-11 years. more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
NEC technology reliably measures sea levels from a greater distance
Jul 16, 2024 17:45 JST
|
|
|
全球发展数字经济直播访谈会正式举办 外方来华参会高级别代表走进东方甄选直播间
Jul 16, 2024 15:08 HKT/SGT
|
|
|
巨星传奇(6683.HK)解禁后首个交易日:收盘报10.4港元 升幅达2.97%
Jul 16, 2024 14:58 HKT/SGT
|
|
|
全球發展數字經濟直播訪談會正式舉辦 外方來華參會高級別代表走進東方甄選直播間
Jul 16, 2024 14:25 HKT/SGT
|
|
|
Fujitsu and Cohere launch strategic partnership and joint development to provide generative AI for enterprises
Jul 16, 2024 15:13 JST
|
|
|
エーザイ、ホスラブコナゾールのアジア・オセアニアにおけるライセンス契約を佐藤製薬と締結
Jul 16, 2024 13:00: JST
|
|
|
富士通とCohere、企業向け生成AIの提供に向けた戦略的パートナーシップを締結し、共同開発を開始
Jul 16, 2024 13:00: JST
|
|
|
卓悅集團旗下卓悅奧特萊斯Beauty Outlet開幕
Jul 15, 2024 22:58 HKT/SGT
|
|
|
Malaysian Aviation Commission Handpicks Indonesia's TransNusa Airlines as One of the Two Foreign Airlines to Operate from its distinguished Subang Airport
Jul 15, 2024 22:00: JST
|
|
|
Malaysian Aviation Commission Handpicks Indonesia's TransNusa Airlines as One of the Two Foreign Airlines to Operate from its distinguished Subang Airport
Jul 15, 2024 21:00 HKT/SGT
|
|
|
卓悦集团旗下卓悦奥特莱斯Beauty Outlet开幕
Jul 15, 2024 20:56 HKT/SGT
|
|
|
Moolec Signs an Offtake Agreement With Major Global CPG Company to Hit the US Market in 2025
Jul 15, 2024 19:00 HKT/SGT
|
|
|
Telin and BW Digital to enhance DC-to-DC connectivity with new Indonesia - Singapore cable
Jul 15, 2024 17:50 HKT/SGT
|
|
|
Legend Capital's Portfolio Company Singfilm Solar Achieves Breakthrough in Perovskite Solar Cell Efficiency
Jul 15, 2024 17:10 HKT/SGT
|
|
|
NEC transfers a portion of its shares in NEC Capital Solutions, an equity method affiliate
Jul 15, 2024 16:58 JST
|
|
|
|
More News >> |
|
|
|
|
|